Related Experiment Video
Updated: Dec 11, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications
Kelly H Zou1, Jim Z Li2, Joseph Imperato3
1Research, Development and Medical, Upjohn Division, Pfizer Inc, New York, NY 10017, USA.
Real-world data (RWD) from diverse sources can generate real-world evidence (RWE) for drug insights. Harnessing RWD faces challenges, but artificial intelligence offers potential solutions for improved healthcare.
Area of Science:
- Health Informatics
- Clinical Research
- Data Science
Background:
- Vast amounts of real-world data (RWD) are accessible from numerous healthcare sources.
- RWD analysis yields real-world evidence (RWE), crucial for understanding drug usage, benefits, and risks.
Purpose of the Study:
- To define and explain real-world data (RWD) and real-world evidence (RWE).
- To detail the utilization of RWD and RWE by regulatory authorities.
- To explore challenges and the role of artificial intelligence in RWD analysis.
Main Methods:
- Review of existing literature and regulatory practices concerning RWD and RWE.
- Identification and categorization of diverse RWD sources (EHRs, claims, registries, devices, apps).
- Analysis of structured and unstructured data types within RWD.
Main Results:
- RWD encompasses a wide array of information from various healthcare touchpoints.
- RWE provides critical insights into drug performance and safety in real-world settings.
- Regulatory bodies are increasingly incorporating RWE into their decision-making processes.
Conclusions:
- Harnessing RWD is complex due to data heterogeneity and volume.
- Artificial intelligence presents a promising avenue for overcoming RWD challenges.
- Effective RWD and RWE utilization, supported by AI, can significantly advance global health outcomes.
More Related Videos
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
09:43Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
Published on: November 22, 2019
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Regulation
Global Regulatory Systems
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...